David Ralph

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

David B. Badesch, Victor F. Tapson, Michael D. McGoon et al. · Annals of Internal Medicine · 2000 · 1.1K citations

Medicine, Pharmacotherapy, Cardiopulmonary Rehabilitation +10

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology · 2002 · 823 citations

Medicine, Clinical Sciences, Internal Medicine +16

Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer

Robert W. Veltri, Michael Craig Miller, Gang Zhao et al. · Urology · 1999 · 171 citations

Medicine, Endocrinology, Urology +16

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

Alan L. Hinderliter, Park W. Willis, Walker Long et al. · The American Journal of Cardiology · 1999 · 166 citations

Medicine, Cardiology, Internal Medicine +12

Rapidly progressive air-flow abstruction in marrow transplant recipients.

David Ralph · Medical Entomology and Zoology · 1984 · 109 citations

Medicine, Hematology, Stem Cell Transplantation +5